Michael Robert Martin, Chief Business Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 116,000 shares at $21.71 ($2.7M) on 2021-09-20, disclosed to the SEC on 2021-09-22.
Open-market sale of $2.7M AUPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.60 | 16,000 | $346K | 12.7% |
| 2 | $21.71 | 12,500 | $271K | 10.0% |
| 3 | $24.02 | 87,500 | $2.1M | 77.3% |
| Total | $23.44 avg | 116,000 | $2.7M | 100% |
| Filing → |
| AUPH | SELL | 2021-11-12 | $4.5M | — | Filing → |
| AUPH | SELL | 2021-11-03 | $1.4M | — | Filing → |
| AUPH | SELL | 2021-09-16 | $958K | — | Filing → |